{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:49:34Z","timestamp":1792601374663,"version":"4.5.0"},"reference-count":36,"publisher":"American Diabetes Association","issue":"5","license":[{"start":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T00:00:00Z","timestamp":1587340800000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["316644"],"award-info":[{"award-number":["316644"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF OC0013659"],"award-info":[{"award-number":["NNF OC0013659"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>The aim of this study was to quantify the excess risk of autoimmune hypothyroidism and hyperthyroidism, Addison disease, celiac disease, and atrophic gastritis in adults with type 1 diabetes (T1D) compared with nondiabetic individuals in Finland.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>The study included 4,758 individuals with T1D from the Finnish Diabetic Nephropathy (FinnDiane) Study and 12,710 nondiabetic control individuals. The autoimmune diseases (ADs) were identified by linking the data with the Finnish nationwide health registries from 1970 to 2015.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>The median age of the FinnDiane individuals at the end of follow-up in 2015 was 51.4 (interquartile range 42.6\u201360.1) years, and the median duration of diabetes was 35.5 (26.5\u201344.0) years. Of individuals with T1D, 22.8% had at least one additional AD, which included 31.6% of women and 14.9% of men. The odds ratios for hypothyroidism, hyperthyroidism, celiac disease, Addison disease, and atrophic gastritis were 3.43 (95% CI 3.09\u20133.81), 2.98 (2.27\u20133.90), 4.64 (3.71\u20135.81), 24.13 (5.60\u2013104.03), and 5.08 (3.15\u20138.18), respectively, in the individuals with T1D compared with the control individuals. The corresponding ORs for women compared with men were 2.96 (2.53\u20133.47), 2.83 (1.87\u20134.28), 1.52 (1.15\u20132.02), 2.22 (0.83\u20135.91), and 1.36 (0.77\u20132.39), respectively, in individuals with T1D. Late onset of T1D and aging increased the risk of hypothyroidism, whereas young age at onset of T1D increased the risk of celiac disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>This is one of the largest studies quantifying the risk of coexisting AD in adult individuals with T1D in the country with the highest incidence of T1D in the world. The results highlight the importance of continuous screening for other ADs in individuals with T1D.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc19-2429","type":"journal-article","created":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T22:15:33Z","timestamp":1583446533000},"page":"1041-1047","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":65,"title":["Every Fifth Individual With Type 1 Diabetes Suffers From an Additional Autoimmune Disease: A Finnish Nationwide Study"],"prefix":"10.2337","volume":"43","author":[{"given":"Sari","family":"M\u00e4kimattila","sequence":"first","affiliation":[{"name":"Endocrinology and Diabetes, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3568-9779","authenticated-orcid":false,"given":"Valma","family":"Harjutsalo","sequence":"additional","affiliation":[{"name":"Folkh\u00e4lsan Institute of Genetics, Folkh\u00e4lsan Research Center, Biomedicum Helsinki, Helsinki, Finland"},{"name":"Nephrology, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland"},{"name":"Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland"},{"name":"National Institute for Health and Welfare, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Forsblom","sequence":"additional","affiliation":[{"name":"Folkh\u00e4lsan Institute of Genetics, Folkh\u00e4lsan Research Center, Biomedicum Helsinki, Helsinki, Finland"},{"name":"Nephrology, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland"},{"name":"Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4055-6954","authenticated-orcid":false,"given":"Per-Henrik","family":"Groop","sequence":"additional","affiliation":[{"name":"Folkh\u00e4lsan Institute of Genetics, Folkh\u00e4lsan Research Center, Biomedicum Helsinki, Helsinki, Finland"},{"name":"Nephrology, Abdominal Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland"},{"name":"Research Program for Clinical and Molecular Metabolism, University of Helsinki, Helsinki, Finland"},{"name":"Department of Diabetes, Central Clinical School, Monash University, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2020,3,5]]},"reference":[{"key":"2022031300340980400_B1","doi-asserted-by":"crossref","first-page":"16899","DOI":"10.1073\/pnas.1009511107","article-title":"Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis","volume":"107","author":"Menconi","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031300340980400_B2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1530\/EJE-18-0515","article-title":"Associated auto-immune disease in type 1 diabetes patients: a systematic review and meta-analysis","volume":"180","author":"Nederstigt","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"2022031300340980400_B3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1083-3188(99)00023-6","article-title":"Premenarchal and postmenarchal girls with insulin-dependent diabetes mellitus: ovarian and other organ-specific autoantibodies, menstrual cycle","volume":"12","author":"Snajderov\u00e1","year":"1999","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2022031300340980400_B4","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2337\/diacare.28.4.850","article-title":"Autoantibody \u201csubspecificity\u201d in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups","volume":"28","author":"Barker","year":"2005","journal-title":"Diabetes Care"},{"key":"2022031300340980400_B5","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2174\/138920207783591690","article-title":"The HLA region and autoimmune disease: associations and mechanisms of action","volume":"8","author":"Gough","year":"2007","journal-title":"Curr Genomics"},{"key":"2022031300340980400_B6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11892-015-0668-4","article-title":"Progress in understanding type 1 diabetes through its genetic overlap with other autoimmune diseases","volume":"15","author":"Roizen","year":"2015","journal-title":"Curr Diab Rep"},{"key":"2022031300340980400_B7","doi-asserted-by":"crossref","first-page":"e20171305","DOI":"10.1542\/peds.2017-1305","article-title":"Co-occurrence of type 1 diabetes and celiac disease autoimmunity","volume":"140","author":"Hagopian","year":"2017","journal-title":"Pediatrics"},{"key":"2022031300340980400_B8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.2013.8399","article-title":"Incidence of type 1 diabetes in Finland","volume":"310","author":"Harjutsalo","year":"2013","journal-title":"JAMA"},{"key":"2022031300340980400_B9","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/apt.14335","article-title":"Declining trend in the incidence of biopsy-verified coeliac disease in the adult population of Finland, 2005-2014","volume":"46","author":"Virta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"2022031300340980400_B10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/dme.12318","article-title":"Thyroid autoimmunity in type 1 diabetes: systematic review and meta-analysis","volume":"31","author":"Shun","year":"2014","journal-title":"Diabet Med"},{"key":"2022031300340980400_B11","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.2337\/diacare.28.9.2170","article-title":"The role of autoimmunity at diagnosis of type 1 diabetes in the development of thyroid and celiac disease and microvascular complications","volume":"28","author":"Glastras","year":"2005","journal-title":"Diabetes Care"},{"key":"2022031300340980400_B12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0022-3476(74)80462-2","article-title":"Coexistence of diabetes mellitus and celiac disease","volume":"85","author":"Thain","year":"1974","journal-title":"J Pediatr"},{"key":"2022031300340980400_B13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/pmj.76.894.230","article-title":"Addison\u2019s disease in type 1 diabetes presenting with recurrent hypoglycaemia","volume":"76","author":"McAulay","year":"2000","journal-title":"Postgrad Med J"},{"key":"2022031300340980400_B14","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.2337\/diacare.28.8.2019","article-title":"Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study)","volume":"28","author":"Thorn","year":"2005","journal-title":"Diabetes Care"},{"key":"2022031300340980400_B15","volume-title":"Generalized Additive Models","author":"Hastie","year":"1990"},{"key":"2022031300340980400_B16","doi-asserted-by":"crossref","DOI":"10.1201\/9781420010404","volume-title":"Generalized Additive Models: An Introduction with R","author":"Wood","year":"2006"},{"key":"2022031300340980400_B17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1210\/jcem.87.2.8182","article-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)","volume":"87","author":"Hollowell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031300340980400_B18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.yfrne.2014.04.004","article-title":"Gender differences in autoimmune disease","volume":"35","author":"Ngo","year":"2014","journal-title":"Front Neuroendocrinol"},{"key":"2022031300340980400_B19","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(08)60765-5","article-title":"Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study","volume":"371","author":"Harjutsalo","year":"2008","journal-title":"Lancet"},{"key":"2022031300340980400_B20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2007.05.002","article-title":"Epidemiology of autoimmune diseases in Denmark","volume":"29","author":"Eaton","year":"2007","journal-title":"J Autoimmun"},{"key":"2022031300340980400_B21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/ni0901-777","article-title":"Sex differences in autoimmune disease","volume":"2","author":"Whitacre","year":"2001","journal-title":"Nat Immunol"},{"key":"2022031300340980400_B22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/dc18-1157","article-title":"Late-onset T1DM and older age predict risk of additional autoimmune disease","volume":"42","author":"Hughes","year":"2019","journal-title":"Diabetes Care"},{"key":"2022031300340980400_B23","doi-asserted-by":"crossref","first-page":"E177","DOI":"10.1210\/jc.2013-2852","article-title":"HLA class II haplotypes differentiate between the adult autoimmune polyglandular syndrome types II and III","volume":"99","author":"Flesch","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031300340980400_B24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/cei.13115","article-title":"A quarter of patients with type 1 diabetes have co-existing non-islet autoimmunity: the findings of a UK population-based family study","volume":"192","author":"Kozhakhmetova","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"2022031300340980400_B25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40618-014-0214-2","article-title":"Role of genetic and non-genetic factors in the etiology of Graves\u2019 disease","volume":"38","author":"Marin\u00f2","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"2022031300340980400_B26","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/cen.12222","article-title":"Smoking and thyroid","volume":"79","author":"Wiersinga","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2022031300340980400_B27","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1080\/00365520903030795","article-title":"Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults","volume":"44","author":"Virta","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"2022031300340980400_B28","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","article-title":"Global prevalence of celiac disease: systematic review and meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2022031300340980400_B29","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.2337\/diacare.22.12.1950","article-title":"Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group","volume":"22","author":"Komulainen","year":"1999","journal-title":"Diabetes Care"},{"key":"2022031300340980400_B30","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.autrev.2018.05.013","article-title":"Celiac disease and endocrine autoimmunity - the genetic link","volume":"17","author":"Kahaly","year":"2018","journal-title":"Autoimmun Rev"},{"key":"2022031300340980400_B31","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2337\/diabetes.51.1.210","article-title":"High familial risk and genetic susceptibility in early onset childhood diabetes","volume":"51","author":"Gillespie","year":"2002","journal-title":"Diabetes"},{"key":"2022031300340980400_B32","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12020-016-0916-7","article-title":"Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison\u2019s disease","volume":"53","author":"Fichna","year":"2016","journal-title":"Endocrine"},{"key":"2022031300340980400_B33","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1210\/jc.2018-02064","article-title":"Early clinical indicators of addison disease in adults with type 1 diabetes: a nationwide, observational, cohort study","volume":"104","author":"Chantzichristos","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031300340980400_B34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1530\/EJE-17-0751","article-title":"Incidence, prevalence and seasonal onset variation of Addison's disease among persons with type 1 diabetes mellitus: nationwide, matched cohort studies","volume":"178","author":"Chantzichristos","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"2022031300340980400_B35","doi-asserted-by":"crossref","first-page":"e90768","DOI":"10.1371\/journal.pone.0090768","article-title":"Cardiovascular risk factors in patients with Addison\u2019s disease: a comparative study of South African and Swedish patients","volume":"9","author":"Ross","year":"2014","journal-title":"PLoS One"},{"key":"2022031300340980400_B36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1210\/jc.2007-2134","article-title":"Autoimmune gastritis in type 1 diabetes: a clinically oriented review","volume":"93","author":"De Block","year":"2008","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc19-2429","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/5\/1041\/631167\/dc192429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/5\/1041\/631167\/dc192429.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T03:52:12Z","timestamp":1647143532000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/43\/5\/1041\/35693\/Every-Fifth-Individual-With-Type-1-Diabetes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,5]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,3,5]]},"published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc19-2429","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,5]]}}}